A detailed history of Us Bancorp \De\ transactions in Fulgent Genetics, Inc. stock. As of the latest transaction made, Us Bancorp \De\ holds 501 shares of FLGT stock, worth $9,408. This represents 0.0% of its overall portfolio holdings.

Number of Shares
501
Previous 516 2.91%
Holding current value
$9,408
Previous $10,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

SELL
$19.6 - $25.06 $294 - $375
-15 Reduced 2.91%
501 $10,000
Q2 2024

Aug 06, 2024

BUY
$19.09 - $22.57 $6,166 - $7,290
323 Added 167.36%
516 $10,000
Q1 2024

May 07, 2024

SELL
$21.55 - $29.29 $9,137 - $12,418
-424 Reduced 68.72%
193 $4,000
Q4 2023

Feb 09, 2024

BUY
$23.64 - $30.27 $2,222 - $2,845
94 Added 17.97%
617 $17,000
Q3 2023

Nov 03, 2023

SELL
$26.74 - $40.81 $1,711 - $2,611
-64 Reduced 10.9%
523 $13,000
Q2 2023

Aug 09, 2023

SELL
$28.52 - $40.7 $3,194 - $4,558
-112 Reduced 16.02%
587 $21,000
Q1 2023

May 09, 2023

BUY
$29.39 - $36.27 $14,048 - $17,337
478 Added 216.29%
699 $21,000
Q4 2022

Feb 13, 2023

SELL
$29.23 - $40.28 $5,816 - $8,015
-199 Reduced 47.38%
221 $6,000
Q3 2022

Oct 27, 2022

SELL
$37.92 - $63.74 $2,768 - $4,653
-73 Reduced 14.81%
420 $16,000
Q2 2022

Aug 01, 2022

SELL
$47.98 - $62.75 $19,575 - $25,602
-408 Reduced 45.28%
493 $27,000
Q1 2022

May 11, 2022

BUY
$49.85 - $96.11 $7,577 - $14,608
152 Added 20.29%
901 $56,000
Q4 2021

Feb 11, 2022

BUY
$77.3 - $105.0 $24,504 - $33,285
317 Added 73.38%
749 $75,000
Q3 2021

Nov 10, 2021

SELL
$74.87 - $110.87 $14,449 - $21,397
-193 Reduced 30.88%
432 $39,000
Q2 2021

Aug 05, 2021

BUY
$66.8 - $100.45 $18,570 - $27,925
278 Added 80.12%
625 $57,000
Q1 2021

Apr 28, 2021

SELL
$59.3 - $183.85 $9,784 - $30,335
-165 Reduced 32.23%
347 $33,000
Q4 2020

Feb 04, 2021

BUY
$31.01 - $52.1 $15,877 - $26,675
512 New
512 $27,000
Q3 2020

Nov 10, 2020

SELL
$15.89 - $50.51 $6,356 - $20,204
-400 Closed
0 $0
Q2 2020

Aug 07, 2020

BUY
$8.89 - $18.28 $3,556 - $7,312
400 New
400 $6,000

Others Institutions Holding FLGT

About Fulgent Genetics, Inc.


  • Ticker FLGT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 30,265,800
  • Market Cap $568M
  • Description
  • Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions...
More about FLGT
Track This Portfolio

Track Us Bancorp \De\ Portfolio

Follow Us Bancorp \De\ and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Us Bancorp \De\, based on Form 13F filings with the SEC.

News

Stay updated on Us Bancorp \De\ with notifications on news.